A phase II, multicentre, double blind, randomised, 5-way cross-over study to test the non-inferiority of the acute bronchodilator effect of CHF 1535 200/6 µg NEXThaler versus CHF 1535 100/6 µg NEXThaler in partially controlled and uncontrolled adult asthmatic patients.
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
Price : $35 *
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Chiesi Farmaceutici
- 27 Oct 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
- 18 Apr 2014 New trial record